KBC Group NV raised its holdings in shares of Aptiv PLC (NYSE:APTV – Free Report) by 4.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 73,070 shares of the auto parts company’s stock after acquiring an additional 2,786 shares during the quarter. KBC Group NV’s holdings in Aptiv were worth $5,262,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA lifted its holdings in Aptiv by 15.9% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 12,861,135 shares of the auto parts company’s stock worth $905,681,000 after purchasing an additional 1,764,844 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in shares of Aptiv by 13.7% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 7,515,074 shares of the auto parts company’s stock worth $529,212,000 after buying an additional 905,431 shares in the last quarter. Capital World Investors purchased a new position in Aptiv during the first quarter valued at $343,760,000. EdgePoint Investment Group Inc. bought a new stake in Aptiv in the 1st quarter valued at $335,426,000. Finally, Canada Pension Plan Investment Board lifted its stake in Aptiv by 18.1% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,485,374 shares of the auto parts company’s stock worth $277,610,000 after purchasing an additional 533,779 shares in the last quarter. 94.21% of the stock is currently owned by hedge funds and other institutional investors.
Aptiv Price Performance
Aptiv stock opened at $52.93 on Monday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.50 and a quick ratio of 1.06. The stock has a market cap of $12.44 billion, a price-to-earnings ratio of 5.91, a price-to-earnings-growth ratio of 0.47 and a beta of 1.81. The firm has a 50-day moving average of $66.50 and a two-hundred day moving average of $71.35. Aptiv PLC has a 1 year low of $52.14 and a 1 year high of $91.66.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on APTV shares. Morgan Stanley cut their price objective on Aptiv from $68.00 to $60.00 and set an “underweight” rating for the company in a research report on Thursday. JPMorgan Chase & Co. upped their price objective on Aptiv from $107.00 to $113.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Bank of America cut their target price on shares of Aptiv from $105.00 to $102.00 and set a “buy” rating for the company in a report on Monday, October 14th. Nomura Securities upgraded shares of Aptiv from a “strong sell” rating to a “hold” rating in a research report on Monday, August 19th. Finally, Wolfe Research initiated coverage on shares of Aptiv in a report on Thursday, September 5th. They issued an “outperform” rating and a $89.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Aptiv has an average rating of “Moderate Buy” and an average target price of $86.53.
View Our Latest Analysis on Aptiv
Aptiv Company Profile
Aptiv PLC engages in design, manufacture, and sale of vehicle components in North America, Europe, Middle East, Africa, the Asia Pacific, South America, and internationally. The company provides electrical, electronic, and safety technology solutions to the automotive and commercial vehicle markets. It operates through two segments, Signal and Power Solutions, and Advanced Safety and User Experience.
Featured Stories
- Five stocks we like better than Aptiv
- Manufacturing Stocks Investing
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 5 discounted opportunities for dividend growth investors
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Airline Stocks – Top Airline Stocks to Buy Now
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Aptiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptiv and related companies with MarketBeat.com's FREE daily email newsletter.